p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia-reperfusion injury
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
In many clinical settings, the duration of renal ischemia and therefore the outcome of acute renal failure cannot be determined adequately. Renal ischemia reperfusion injury is known to shorten telomeres and upregulate stress-induced genes, such as the cyclin-dependent kinase (CDK) inhibitor p21. So far, the expression and role of CDK inhibitors, as well as mouse telomerase reverse transcriptase (mTERT), has not been investigated in a model with variable lasting ischemic periods. Male C57Bl/6 mice were subjected to renal ischemia reperfusion injury by clamping both renal pedicles for 10, 20, 30, and 45 min, and the kidneys were allowed to be reperfused for 3, 24, and 48 h. Expression of different CDK inhibitors and mTERT was evaluated. Mice developed signs of acute renal failure linear to the duration of the ischemic period. Real-time PCR revealed that mTERT was only significantly upregulated in kidneys after short ischemic periods (20 min). In contrast, p21 was constantly upregulated in kidneys after long ischemic intervals (30 and 45 min), but not in kidneys, which were clamped for shorter periods. Mainly, tubular cells contributed to the observed increase in p21 expression. Targeting p21 via the selective p53 inhibitor pifithrin-α was able to prevent acute renal failure when administered immediately before ischemia. The expression of another CDK inhibitor, namely p16, was differentially regulated, depending on the time of reperfusion. Taken together, we detected mTERT and p21 as “indicator” genes for short and long ischemic intervals, respectively. These two proteins might also be possible new therapeutic targets in the treatment and prevention of acute renal failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349 · cited 1×
“Interestingly, gene knockout experiments revealed that mTERT / mice had no obvious abnormalities in early generations, although significant telomere shortening was observed in successive generations (27).”
BackgroundMelk, A., Schmidt, B. M. W., Vongwiwatana, A., Rayner, D. C., & Halloran, P. F. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00846.x · Cited by 154 · cited 1×
“Melk and coworkers (21) provided compelling evidence that an increased p16 expression is directly correlated with increased tubular atrophy, interstitial fibrosis, and impaired function in renal allografts.”
BackgroundPositive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure
Megyesi, J., Andrade, L., Vieira, J. M., Safirstein, R. L., & Price, P. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00044.x · Cited by 153
Cited by
Cellular senescence in renal ageing and disease
Sturmlechner, I., Durik, M., Sieben, C. J., Baker, D. J., & van Deursen, J. M. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.183 · Cited by 345
Molecular mechanisms of renal aging
Schmitt, R., & Melk, A. (2017) · Kidney International · doi:10.1016/j.kint.2017.02.036 · Cited by 235
Nrf2 attenuates ferroptosis-mediated IIR-ALI by modulating TERT and SLC7A11
Dong, H., Xia, Y., Jin, S., Xue, C., Wang, Y., Hu, R., & Jiang, H. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04307-1 · Cited by 196
Cellular senescence in the aging and diseased kidney
Valentijn, F. A., Falke, L. L., Nguyen, T. Q., & Goldschmeding, R. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0434-2 · Cited by 173
“…p16-KO Long term (21d): reduced interstitial fibrosis, reduced nephron atrophy Detrimental: contributing to adverse long-term allograft outcomes (Hochegger et al. 2007) IRI p53 inhibition via pifithrin-α Acute (<48 h of reperfusion): reduced serum creatinine, reduced tubular necrosis…”
BackgroundWesthoff, J. H., Hilgers, K. F., Steinbach, M. P., Hartner, A., Klanke, B., Amann, K., & Melk, A. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.099432 · Cited by 152
Metadata
- Authors
- Hochegger, K., Koppelstaetter, C., Tagwerker, A., Huber, J. M., Heininger, D., Mayer, G., & Rosenkranz, A. R.
- Venue
- American Journal of Physiology-Renal Physiology
- Publisher
- American Physiological Society
- Published
- 2007-02
- Volume
- 292
- Issue
- 2
- Pages
- F762-F768
- ISSN
- 1522-1466 (ISSN-L)
- 1931-857X
- OpenAlex
- W2036043060
- Cited by
- 41
- References
- 4
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia-reperfusion injury. https://app.cochat.ai/papers/10.1152/ajprenal.00084.2006
- The paper
- Hochegger, K., Koppelstaetter, C., Tagwerker, A., Huber, J. M., Heininger, D., Mayer, G., & Rosenkranz, A. R. (2007). p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia-reperfusion injury. American Journal of Physiology-Renal Physiology. https://doi.org/10.1152/ajprenal.00084.2006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.